Istituto Biochimico Italiano Giovanni Lorenzini (IBI-Lorenzini) and Celonic AG have entered a co-development agreement to establish a reliable and substantial development platform to their clients worldwide.

Pursuant to the agreement, the two partners will jointly indulge in the development of high-performance, GMP-compliant cell lines for research and development (R&D).

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Resolution Biosciences and Leidos Biomedical Research have entered an agreement to evaluate the former’s proprietary ctDx platform chemistry and bioinformatics data analysis pipeline.

According to the agreement, Leidos Biomedical Research is responsible for evaluating liquid biopsy technologies to detect all forms of mutations from clinical specimens.

"Sanofi plans to raise gross proceeds of $948.5m through a public offering of notes, due September 2022."

The agreement enables the partners to further develop and evaluate the use of the ctDX platform in clinical trials.

See Also:

Sanofi plans to raise gross proceeds of $948.5m through a public offering of notes, due September 2022. The company intends to utilise the funds for general corporate purposes.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Pharmaceutical International has raised $93m in a venture financing round led by Signet Healthcare Partners along with Athyrium Capital Management LP, Hildred Capital Partners LLC and Pharmascience Inc.

The company plans to use the funds to develop its formulation capabilities, commercial manufacturing and generic products pipeline.

Image: Sanofi plans to raise gross proceeds of $948.5m through a public offering of notes, due September 2022. Photo: courtesy of Tangopaso.